Skip to content

Clinical study of botulinum toxin type A in the treatment of knee osteoarthritis

Clinical study of botulinum toxin type A in the treatment of knee osteoarthritis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17011068
Enrollment
Unknown
Registered
2017-04-05
Start date
2017-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis

Interventions

Test group:botulinum toxin type A
Control:Placebo

Sponsors

The Affiliated Hospital of Qingdao University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
38 Years to No maximum

Inclusion criteria

Inclusion criteria: The American College of Rheumatology Clinical Classification Criteria for Osteoarthritis of the Knee One must have articular knee pain for most days of the prior month, in addition to at least 3 of the following: 1. Crepitus on active joint motion; 2. Morning stiffness 38 years; 4. Bony enlargement of the knee on examination; 5. Bony tenderness of the knee on examination; 6. No palpable warmth.

Exclusion criteria

Exclusion criteria: 1. joint space was significantly narrow or knee joints form bone bridge connections leading to bony stiffness; 2. knee joint with obvious varus deformity; 3. other arthropathies such as knee tumor, rheumatoid arthritis, gouty arthritis,tuberculosis, intra-articular fractures, acute traumatic infection or severe peripheral neuropathy; 4. any form of previous lower extremities surgery on ipsilateral lower limbs within 3 months, such as replacement or ligament repair; 5. receiving an IA injection into the affected knee within 3 months; 6. Combined with cardiovascular, liver, kidney, hematopoietic system and other serious primary disease or mental illness; 7. blood coagulation disorders or anticoagulant drug use; 8. pregnancy or lactation.

Design outcomes

Primary

MeasureTime frame
VAS score;WOMAC osteoarthritis index score;WOMAC osteoarthritis index score;

Secondary

MeasureTime frame
40 meters walking time;Knee joint ultrasound;Infrared thermal imaging of the knee;

Countries

China

Contacts

Public ContactTieshan Li

The Affiliated Hospital of Qingdao University

tieshanl@126.com+86 13964282582

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026